Merck Sharp & Dohme (MSD) is a leading international pharmaceutical products and services company. A subsidiary of the innovative research based American pharmaceutical company Merck & Co, Inc, MSD discovers, develops and markets a broad range of products designed to save lives, improve human health and enhance patient's quality of life.

The company's products have been available in South Africa since 1917. The South African head office is located in Midrand where it runs a local manufacturing operation.

MSD's main products are ethical drugs, and it is internationally recognised for its research in many areas, including hypertension, hypercholesterolaemia, HIV/AIDS, osteoporosis, asthma, migraine, arthritis and male pattern hair loss.

Today, more than 4 000 scientists worldwide continue to investigate treatments for a wide range of diseases. Recent discoveries have placed the company at the forefront of research into osteoporosis, asthma and migraine.

This commitment to scientific excellence and breakthrough medicine enables the company to share its knowledge, gained over many years, with local practitioners and specialists to the ultimate benefit of the patient.

MSD also conducts extensive Continuing Medical Education (CME) programmes on an on-going basis around the country in support of the country's Continuing Professional Development (CPD) accreditation programme.